alexa Reactive Oxygen Species Promote Doxorubicin-induced P-gp Expression In Colon Cancer Cells
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

JOINT EVENT:19th Euro Congress on Cancer Science and Therapy & 25th Cancer Nursing & Nurse Practitioners Conference
July 17-19, 2017 Lisbon, Portugal

Martha L Pinzon-Daza, Yenith Cuellar-Saenz, Francisco Nualart, Alejandro OndoMendez, Fabio Castillo-Rivera, Lilia Del Riesgo and Ruth Garzon
Universidad del Rosario, Colombia
Universidad Nacional de Colombia, Colombia
Universidad de ConcepciĆ³n, Chile
Posters & Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-106
Multidrug resistance (MDR) could be one of the most important problems associated to chemotherapy. P-glycoprotein (P-gp) and BCRP (breast cancer resistant protein) are ABC transporters that could be expressed in different cancer cell lines resistant to various drugs used for the treatment of cancer. Many of the anti-tumor chemotherapeutics like doxorubicin, induces reactive oxygen species (ROS) at a high level. In this study we investigated if doxorubicin-induced ROS generation could be involved on P-gp and BCRP expression promoting MDR in colon cancer cells. We analyzed ROS accumulation, Pgp and BCRP expression by qPCR and the relationship between doxorubicin uptake and ABC transporters expression by confocal microscopy using HT-29 WT and HT- 29 Doxorubicin-resistant colon cancer cells (HT-29Doxo) treated with doxorubicin. We used N-acetyl cysteine (NAC) as a control of ROS and APE-1 endonuclease inhibitor E-3330 as a modulator of oxidative stress activity. We showed that doxorubicin-induced ROS generation occurs in a time-dependent manner. Increasing ROS accumulation induced a slowly increased Pgp expression in HT29-WT treated whit doxorubicin and NAC similar to cells treated whit doxorubicin alone. In contrast BCRP expression had a significant reduction whit doxorubicin use and NAC. Furthermore APE-1 inhibitor E3330 induced Pgp and BCRP downregulation and at the same time an increased on doxorubicin accumulation higher than cells no treated. Our results suggest that MDR could be modulated by a mechanism associated to oxidative stress produce by use of doxorubicin in colon cancer cells. Additionally disrupting ROS accumulation could favor cancer therapy.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version